ROSES: Role of self-monitoring of blood glucose and intensive education in patients with Type2 diabetes not receiving insulin. A pilot randomized clinical trial

Diabetic Medicine

Volumn 28, Issue 7, 2011, Pages 789-796

  Franciosi, M ^a   Lucisano, G ^a   Pellegrini, F ^a   Cantarello, A ^b   Consoli, A ^c   Cucco, L ^c   Ghidelli, R ^d   Sartore, G ^b   Sciangula, L ^d   Nicolucci, A ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b Ospedale dei Colli   (Italy)

^c SPIRITO SANTO HOSPITAL   (Italy)

^d UOS di Diabetologia e Malattie Metaboliche ^*  (Italy)

Author keywords

HbA1c; Randomized controlled trial; Self monitoring of blood glucose; Type2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; METABOLIC REGULATION; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; TELEPHONE; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; FEASIBILITY STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; QUALITY OF LIFE;

EID: 79958816342     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03268.x     Document Type: Article

References (19)

1. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 2006; 29: S4-S42.
2. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA et al. Self-monitoring of blood glucose in patients with type2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 1510-1517.
3. Sarol JN Jr, Nicodemus NA Jr, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin-requiring type2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin 2005; 21: 173-184.
4. Clar C, Barnard K, Cummins E, Royle P, Waugh N. Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type2 diabetes: systematic review. Health Technol Assess 2010; 14: 1-140.
5. Poolsup N, Suksomboon N, Jlamsathit W. Systematic review of the benefit of self-monitoring of blood glucose on glycemic control in type2 diabetes patients. Diabetes Technol Ther 2008; 10: S51-S66.
6. Bergenstal RM, Gavin JR 3rd. Global Consensus Conference on Glucose Monitoring Panel. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 2005; 118: 1S-6S.
7. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001; 24: 1870-1877.
8. Brown JB, Nichols GA. Slow response to loss of glycemic control in type2 diabetes mellitus. Am J Manag Care 2003; 9: 213-217.
9. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004; 164: 2090-2095.
10. Davidson MB. Counterpoint: self-monitoring of blood glucose in type2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 2005; 28: 1531-1533.
11. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press, 2003.
12. Kolb H, Kempf K, Martin S, Stumvoll M, Landgraf R. On what evidence base do we recommend self-monitoring of blood glucose? Diabetes Res Clin Pract 2010; 87: 150-156.
13. O'Kane MJ, Bunting B, Copeland M, Coates VE; ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type2 diabetes (ESMON study): randomised controlled trial. Br Med J 2008; 336: 1174-1177.
14. Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M et al. The efficacy of self-monitoring of blood glucose in the management of patients with type2 diabetes treated with a gliclazide modified release-based regimen. A multi-centre, randomized, parallel-group, 6-month evaluation (DINAMIC1 study). Diabetes Obes Metab 2008; 10: 1239-1247.
15. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. Br Med J 2007; 335: 132.
16. Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A et al.; DiGEM Trial Group Blood glucose self-monitoring in type2 diabetes: a randomised controlled trial. Health Technol Assess 2009; 13: 1-50.
17. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422-425.
18. Schwedes U, Siebolds M, Mertes G; SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type2 diabetic patients. Diabetes Care 2002; 25: 1928-1932.
19. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. Br Med J 2008; 336: 601-605.